Michael B Weinstock1, Scott Weingart2, Frank Orth3, Douglas VanFossen4, Colin Kaide5, Judy Anderson6, David H Newman7. 1. Department of Emergency Medicine, Wexner Medical Center at The Ohio State University, Columbus2Department of Emergency Medicine, Mount Carmel St. Ann's, Westerville, Ohio. 2. Division of Emergency Critical Care, Stony Brook Medicine, Stony Brook, New York. 3. Department of Emergency Medicine, Mount Carmel St. Ann's, Westerville, Ohio. 4. Division of Cardiology, Mount Carmel St. Ann's, Westerville, Ohio. 5. Department of Emergency Medicine, Wexner Medical Center at The Ohio State University, Columbus. 6. Mount Carmel Health System, Columbus, Ohio. 7. Department of Emergency Medicine, Icahn School of Medicine, New York, New York.
Abstract
IMPORTANCE: Patients with potentially ischemic chest pain are commonly admitted to the hospital or observed after a negative evaluation in the emergency department (ED) owing to concern about adverse events. Previous studies have looked at 30-day mortality, but no current large studies have examined the most important information regarding ED disposition: the short-term risk for a clinically relevant adverse cardiac event (including inpatient ST-segment elevation myocardial infarction, life-threatening arrhythmia, cardiac or respiratory arrest, or death). OBJECTIVE: To determine the incidence of clinically relevant adverse cardiac events in patients hospitalized for chest pain with 2 troponin-negative findings, nonconcerning initial ED vital signs, and nonischemic, interpretable electrocardiographic findings. DESIGN, SETTING, AND PARTICIPANTS: We conducted a blinded data review of 45,416 encounters obtained from a prospectively collected database enrolling adult patients admitted or observed with the following inclusion criteria: (1) primary presenting symptom of chest pain, chest tightness, chest burning, or chest pressure and (2) negative findings for serial biomarkers. Data were collected and analyzed from July 1, 2008, through June 30, 2013, from the EDs of 3 community teaching institutions with an aggregate census of more than 1 million visits. We analyzed data extracted by hypothesis-blinded abstractors. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of life-threatening arrhythmia, inpatient ST-segment elevation myocardial infarction, cardiac or respiratory arrest, or death during hospitalization. RESULTS: Of the 45,416 encounters, 11,230 met criteria for inclusion. Mean patient age was 58.0 years. Of the 11 230 encounters, 44.83% of patients arrived by ambulance and 55.00% of patients were women. Relevant history included hypertension in 46.00%, diabetes mellitus in 19.72%, and myocardial infarction in 13.16%. The primary end point occurred in 20 of the 11 230 patients (0.18% [95% CI, 0.11%-0.27%]). After excluding patients with abnormal vital signs, electrocardiographic ischemia, left bundle branch block, or a pacemaker rhythm, we identified a primary end point event in 4 of 7266 patients (0.06% [95% CI, 0.02%-0.14%]). Of these events, 2 were noncardiac and 2 were possibly iatrogenic. CONCLUSIONS AND RELEVANCE: In adult patients with chest pain admitted with 2 negative findings for serial biomarkers, nonconcerning vital signs, and nonischemic electrocardiographic findings, short-term clinically relevant adverse cardiac events were rare and commonly iatrogenic, suggesting that routine inpatient admission may not be a beneficial strategy for this group.
IMPORTANCE: Patients with potentially ischemic chest pain are commonly admitted to the hospital or observed after a negative evaluation in the emergency department (ED) owing to concern about adverse events. Previous studies have looked at 30-day mortality, but no current large studies have examined the most important information regarding ED disposition: the short-term risk for a clinically relevant adverse cardiac event (including inpatient ST-segment elevation myocardial infarction, life-threatening arrhythmia, cardiac or respiratory arrest, or death). OBJECTIVE: To determine the incidence of clinically relevant adverse cardiac events in patients hospitalized for chest pain with 2 troponin-negative findings, nonconcerning initial ED vital signs, and nonischemic, interpretable electrocardiographic findings. DESIGN, SETTING, AND PARTICIPANTS: We conducted a blinded data review of 45,416 encounters obtained from a prospectively collected database enrolling adult patients admitted or observed with the following inclusion criteria: (1) primary presenting symptom of chest pain, chest tightness, chest burning, or chest pressure and (2) negative findings for serial biomarkers. Data were collected and analyzed from July 1, 2008, through June 30, 2013, from the EDs of 3 community teaching institutions with an aggregate census of more than 1 million visits. We analyzed data extracted by hypothesis-blinded abstractors. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of life-threatening arrhythmia, inpatient ST-segment elevation myocardial infarction, cardiac or respiratory arrest, or death during hospitalization. RESULTS: Of the 45,416 encounters, 11,230 met criteria for inclusion. Mean patient age was 58.0 years. Of the 11 230 encounters, 44.83% of patients arrived by ambulance and 55.00% of patients were women. Relevant history included hypertension in 46.00%, diabetes mellitus in 19.72%, and myocardial infarction in 13.16%. The primary end point occurred in 20 of the 11 230 patients (0.18% [95% CI, 0.11%-0.27%]). After excluding patients with abnormal vital signs, electrocardiographic ischemia, left bundle branch block, or a pacemaker rhythm, we identified a primary end point event in 4 of 7266 patients (0.06% [95% CI, 0.02%-0.14%]). Of these events, 2 were noncardiac and 2 were possibly iatrogenic. CONCLUSIONS AND RELEVANCE: In adult patients with chest pain admitted with 2 negative findings for serial biomarkers, nonconcerning vital signs, and nonischemic electrocardiographic findings, short-term clinically relevant adverse cardiac events were rare and commonly iatrogenic, suggesting that routine inpatient admission may not be a beneficial strategy for this group.
Authors: Adam L Sharp; Aileen S Baecker; Ernest Shen; Rita Redberg; Ming-Sum Lee; Maros Ferencik; Shaw Natsui; Chengyi Zheng; Aniket Kawatkar; Michael K Gould; Benjamin C Sun Journal: Ann Emerg Med Date: 2019-02-21 Impact factor: 5.721
Authors: Lane M Smith; Nicklaus P Ashburn; Anna C Snavely; Jason P Stopyra; Kristin M Lenoir; Brian J Wells; Brian C Hiestand; David M Herrington; Chadwick D Miller; Simon A Mahler Journal: Emerg Med J Date: 2020-08-04 Impact factor: 2.740
Authors: Matthew Jay Streitz; Joshua James Oliver; Jessica Marie Hyams; Richard Michael Wood; Yevgeniy Mikhaylovich Maksimenko; Brit Long; Robert Michael Barnwell; Michael David April Journal: Intern Emerg Med Date: 2017-09-11 Impact factor: 3.397
Authors: Adam L Sharp; Aniket A Kawatkar; Aileen S Baecker; Rita F Redberg; Ming-Sum Lee; Maros Ferencik; Yi-Lin Wu; Ernest Shen; Chengyi Zheng; Stacy Park; Steve Goodacre; Praveen Thokala; Benjamin C Sun Journal: J Gen Intern Med Date: 2021-05-14 Impact factor: 5.128
Authors: Salena M Preciado; Adam L Sharp; Benjamin C Sun; Aileen Baecker; Yi-Lin Wu; Ming-Sum Lee; Ernest Shen; Maros Ferencik; Shaw Natsui; Aniket A Kawatkar; Stacy J Park; Rita F Redberg Journal: Ann Emerg Med Date: 2021-01-06 Impact factor: 5.721
Authors: Shaw Natsui; Benjamin C Sun; Ernest Shen; Rita F Redberg; Maros Ferencik; Ming-Sum Lee; Visanee Musigdilok; Yi-Lin Wu; Chengyi Zheng; Aniket A Kawatkar; Adam L Sharp Journal: Circ Cardiovasc Qual Outcomes Date: 2021-01-12